Literature DB >> 9667060

Emotional aspects of hyperprolactinemia.

L G Sobrinho1.   

Abstract

Patients with hyperprolactinemia often present with emotional difficulties. These occasionally persist even after successful treatment. Insight into the roots of their diseased state makes a difference in the handling of all cases, but becomes crucial in the not-so-rare situations in which the normalization of hormonal levels is not followed by a feeling of cure. This chapter attempts to provide details, discuss and situate in context the following blocks of pertinent information: (1) prolactin acts upon the central nervous system and variations in its concentrations do affect mood, emotions and behavior; (2) most actions of prolactin are directed to metabolical and behavioral adaptation to pregnancy and the care of the young; (3) even in the absence of pregnancy prolactin secretion responds to environmental stimuli under specific conditions. Whether adaptive, as in the case of surrogate maternity, or pathological, as in the case of pseudopregnancy, prolactin responds to a perceived need to take care of a child; (4) the facts that the clinical onset of prolactinomas often follows life-events and that these tumors occur preferentially in women brought up under specific conditions suggest the possibility that psychological factors may predispose to prolactinomas; (5) dealing with individual cases requires the perception that the relations between prolactin, emotions and feelings are circular, i.e., prolactin affects the brain and mood but, on the other hand, personality traits and environmental factors may stimulate the secretion of prolactin and may play a role in the genesis of the disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9667060     DOI: 10.1159/000012273

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  7 in total

1.  Effects of the atypical antipsychotics olanzapine and risperidone on plasma prolactin levels in male rats: a comparison with clinical data.

Authors:  Claire Rourke; Kathryn R Starr; Charlie Reavill; Sue Fenwick; Kim Deadman; Declan N C Jones
Journal:  Psychopharmacology (Berl)       Date:  2005-12-07       Impact factor: 4.530

2.  Iron deficiency in infancy predicts altered serum prolactin response 10 years later.

Authors:  Barbara Felt; Elias Jimenez; Julia Smith; Agustin Calatroni; Niko Kaciroti; Gloria Wheatcroft; Betsy Lozoff
Journal:  Pediatr Res       Date:  2006-09-11       Impact factor: 3.756

Review 3.  Management of psychosis associated with a prolactinoma: case report and review of the literature.

Authors:  Shirin Ali; Karen Klahr Miller; Oliver Freudenreich
Journal:  Psychosomatics       Date:  2010 Sep-Oct       Impact factor: 2.386

4.  Quality of life in women with microprolactinoma treated with dopamine agonists.

Authors:  Erika Cesar de Oliveira Naliato; Alice Helena Dutra Violante; Dayse Caldas; Adilson Lamounier Filho; Christiane Rezende Loureiro; Rosita Fontes; Yolanda Schrank; Rodrigo Gomes de Souza; Mario Vaisman; Ermelinda Guerra; Arantzazu Sebastian; Annamaria Colao
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

5.  Circulating prolactin, MPOA prolactin receptor expression and maternal aggression in lactating rats.

Authors:  Angelica R Consiglio; Robert S Bridges
Journal:  Behav Brain Res       Date:  2008-08-13       Impact factor: 3.332

Review 6.  Delusion of pregnancy: a systematic review of 84 cases in the literature.

Authors:  Sagar Chandra Bera; Siddharth Sarkar
Journal:  Indian J Psychol Med       Date:  2015 Apr-Jun

7.  Body self-image disturbances in women with prolactinoma.

Authors:  Helen S Pereira; Erika C Naliato; Aline B Moraes; Monica R Gadelha; Leonardo Vieira Neto; Renan M Almeida; Antonio E Nardi; Alice H Violante
Journal:  Braz J Psychiatry       Date:  2020 Jan-Feb       Impact factor: 2.697

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.